Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

August 30, 2007

Another nasal corticosteroid

Analysis of: Collegium Pharmaceutical provides update on development of its nasal inhaled steroid for allergic rhinitis | www.pipelinereview.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Mitchell Boxer, MD
Assistant Clinical Professor, Albert Einstein College of Medicine
Implications: A new nasal corticosteroid being released by another pharmaceutical company

Analysis: The market is somewhat saturated - I would need to see if this particular drug offers any added benefit in order to determine its role in the already saturated nasal corticosteroid market.

Other Analyses of the Same Source Article:
anything new?
August 22, 2007, Author: GLG Expert Contributor

Report a Concern

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-02T17:45:17.163